Subscribe to RSS - Mick Farrell

Mick Farrell

ResMed sets high expectations for mask sales

Company says it’s ready to ‘unleash’ sales force

SAN DIEGO – ResMed expects to see a nice bump in mask sales in the first quarter of its fiscal year 2018, now that it has manufacturing “sufficiently ramped up” for two new masks, the N20 and F20, says CEO Mick Farrell.

ResMed highlights Brightree’s contribution, mask growth in Q3


SAN DIEGO – It was Brightree that pushed ResMed into double-digit increases for revenues in the third quarter of fiscal year 2017.

Integration begins for ResMed

Company acquired Inova, Brightree in less than three-month span

SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.

ResMed boosts revenue


SAN DIEGO – ResMed reported revenues of $453.9 million for the three months ended March 31, 2016, a 7% increase compared to the same period in 2015. Net income for the quarter was $88.5 million, a 3% decrease compared to the same period in 2015.

Health informatics: ResMed says it has ‘yearlong lead’


SAN DIEGO – The competition in health informatics-driven sleep therapy products is heating up, but ResMed officials say the company is in a good position because it had a head start.

ResMed posts mixed results


SAN DIEGO – ResMed saw a 42% increase in flow generator sales, but a 4% decrease in mask sales for the third quarter ended March 31.

ResMed bets on healthcare informatics


SAN DIEGO – Recent product launches that emphasize connected and data-driven sleep therapy fueled ResMed’s financial results for the second quarter of 2015, CEO Mick Farrell said during a conference call on Jan. 22.

ResMed believes storm has now passed

‘There are green shoots starting to appear’ says CEO Mick Farrell

SAN DIEGO – Competitive bidding helped to drive down ResMed’s revenues in the Americas by 2% for the second quarter ended Dec. 31, 2013, compared to the same period in 2012.

ResMed acknowledges ‘temporary distraction’


SAN DIEGO – Round 2 of competitive bidding has tapped the brakes on ResMed’s growth, officials acknowledged during a conference call Oct. 24 to discuss the company’s first quarter 2014 earnings.

ResMed reports increased income, revenue


SAN DIEGO – ResMed reported net income of $80.9 million for the quarter ended Sept. 30 compared to $71.3 million for the same period last year, a 14% increase.